NIR spectroscopic investigation of two fluoroquinolones, levofloxacin and ofloxacin, and their tablets for qualitative identification of commercial products on the market

Pharmazie

Volumn 63, Issue 9, 2008, Pages 628-632

  Sakamoto, T ^a   Fujimaki, Y ^b   Hiyama, Y ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b TOKYO METROPOLITAN INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN; OFLOXACIN;

ARTICLE; DRUG IDENTIFICATION; DRUG MARKETING; HUMAN; NEAR INFRARED SPECTROSCOPY; QUALITATIVE ANALYSIS; TABLET;

ANTI-BACTERIAL AGENTS; OFLOXACIN; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTROSCOPY, NEAR-INFRARED; TABLETS;

EID: 52649126281     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8107     Document Type: Article

References (22)

1. Barbato F, Morrica P, Seccia S, Ventriglia M (1994) High performance liquid chromatographic analysis of quinolone antibacterial agents. Farmaco 49: 407-410.
2. Barbosa J, Berges R, Sanz-Nebot V (1998) Retention behaviour of quinolone derivatives in high-performance liquid chromatography, Effect of pH and evaluation of ionization constants. J Chromatgr A 823: 411-422.
3. Bauer JF, Elrod Jr. L, Fornnario JR, Heathcote DE, Krogh SK, Linton CL, Norris BJ, Quick JE (1990) Determination of temafloxacin, sarafloxacin, and difloxacin in bulk drug and dosage forms by high-performance liquid chromatography. Pharm Res 7: 1177-1180.
4. El-Hagrasy AS, D'Amico F, Drennen JK (2006) A process analytical technology approach to near-infrared process control of pharmaceutical powder blending. Part I: D-optimal design for characterization of powder mixing and preliminary spectral data evaluation. J Pharm Sci 95: 392-406.
5. El-Hagrasy AS, Drennen JK (2006) A process analytical technology approach to near-infrared process control of pharmaceutical powder blending. Part III: Quantitative near-infrared calibration for prediction of blend homogeneity and characterization of powder mixing kinetics. J Pharm Sci 95: 422-434.
6. Fountain W, Dumstorf K, Lowell AE, Lodder RA, Mumper RJ (2003) Near-infrared spectroscopy for the determination of testosterone in thin-film composites. J Pharm Biomed Anal 33: 181-189.
7. Jernigan JA, Stephens DS, Ashfold DA, Omenaca C, Topiel MS, Galbraith M, Tapper M, Fisk TL, Zaki S, Popovic T, Meyer RF, Quinn CP, Harper SA, Fridkin SK, Sejvar JJ, Shepard CW, McConnel M, Guarner J, Shieh Wun-Ju, Malecki JM, Gerberging JL, Hughes JM, Perkins BA, member of the Anthrax Bioterrorism Investigation Team (2001) Bioterrorism-related inhalational anthrax: The first 10 cases reported in United States. Emerging Infectious Diseases CDC, 7: No. 6.
8. Koechlin C, Jehl F, Linger L, Monteil H (1989) High-performance liquid chromatography for the determination of three new fluoroquinolones, fleroxacin, temafloxacin and A-64730, in biological fluids. J Chromatogr Biom Appl 491: 379-387.
9. Li T, Donner AD, Choi CY, Franzi GP, Morris KR (2003) A statistic support for using spectroscopic methods to validate the content uniformity of solid dosage forms. J Pharm Sci 92: 1526-1530.
10. Luner PE, Patel AD (2005) Quantifying crystal form content in physical mixture of (±)-tartaric acid and (+)-tartaric acid using near infrared reflectance Spectroscopy. AAPS PharmSciTech 6: E245-E252.
11. Medendorp J, Buice Jr. RG, Lodder RA (2006) Acoustic-resonance spectrometry as a process analytical technology for the quantification of active pharmaceutical ingredient in semi-solids. AAPS PharmSciTech 7: E1-E8.
12. Nangia A, Lam F, Cheung-Tak H (1990) Reversed-phase ion-pair high-performance liquid chromatographic determination of fluoroquinolones in human plasma. J Pharm Sci 79: 988-991.
13. O'Neil AJ, Jee RD, Moffat AC (2003) Measurement of the percentage volume particle size distribution of powdered microcrystalline cellulose using reflectance near-infrared spectroscopy. Analyst 128: 1326-1330.
14. Ozaki K (ed.) (1998) "Kinsekigai bunkouho (Near Infrared spectroscopy): Sakurai K. Near infrared spectrometry and experimental method. (IPC, Japan), pp. 71-93. (in Japanese)
15. Sakamoto T, Fujimaki Y, Hiyama Y (2007) Studies on the influence of uniformity of particle size of powder, tapping and sample replacement for diffusion reflectance quantitative NIR spectrometric analysis. Pharmazie 62: 841-846.
16. Sandler N, Rantanen J, Heinamaki J, Romer M, Marvola M, Yliruusi J (2005) Pellet manufacturing by extrusion-spheronization using process analytical technology. AAPS PharmSciTech 6: E174-E183.
17. Scafi SH, Pasquini C (2001) Identification of counterfeit drugs using near-infrared spectroscopy. Analyst 126: 2218-2224.
18. Tyczkowska K, Hedeen KM, Aucoin DP, Aronson AL (1989) High-performance liquid chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue. J Chromatgr Biom Appl 493: 337-346.
19. Westenberger BJ, Ellison CD, Fussner AS, Jenney S, Kolinski RE, Lipe TG, Lyon RC, Moore TW, Revelle LK, Smith AP, Spencer JA, Story KD, Toler DY, Wokovich AM, Buhse LF (2005) Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques. Int J Pharm 306: 56-70.
20. Wright DH, Herman VK, Konstantinides FN, Rotschafer JC (1998) Determination of quinolone antibiotics in growth media by reversed-phase high-performance liquid chromatography. J Chromatogr B 709: 97-104.
21. Yoon WL, Jee RD, Moffat AC (1998) Optimization of sample presentation for the near-infrared spectra of pharmaceutical excipients. Analyst 123: 1029-1034.
22. Zhai S, Korrapati MR, Wei X, Muppalla S, Vestal RE (1995) Simultaneous determination of theophylline, enoxacin and ciprofloxacin in human plasma and saliva by high-performance liquid chromatography. J Chromatogr B 669: 372-376.